Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
MAYNF MAYNE PHARMA GROUP LIMITED
0.1870.0000.00%
NamePositionSalaryService DateEducationAgeGenderUpdated
Mr. Shawn Patrick O’BrienDirector, Managing Director and Chief Executive Officer--------male10/13/2022
Mr. Frank Charles Condella, M.B.A.Chairman of the Board------68male10/13/2022
Dr. Carolyn Myers, M.B.A.,PhDDirector------64female10/13/2022
Mr. Patrick J. BlakeIndependent Director------59male10/13/2022
Ms. Ann Custin, C.P.A.Independent Director------62female10/13/2022
Professor Bruce Robinson, A.C.,F.R.A.C.P.,M.D.Independent Director------66male10/13/2022
Dr. Kathryn MacFarlane, Pharm.D.Independent Director------57female10/13/2022
Mr. David PetrieIndependent Director--------male10/13/2022
Company Overview More
Mayne Pharma Group Ltd. engages in the development and manufacture of proprietary and generic products. It operates through the following segments: Generic Products, Specialty Products, Metrics Contract Services, and Mayne Pharma International. The Generic Products segment is involved in the manufacture and distribution of generic and branded pharmaceutical products. The Metrics Contract Services segment provides contract pharmaceutical services. The Specialty Products segment includes the distribution of branded pharmaceutical products. The Mayne Pharma International segment manufactures and sells branded and generic pharmaceutical products and provides contract manufacturing services to third party customers within Australia. The company was founded in 1845 and is headquartered in Salisbury, Australia.
CEO: Mr. Shawn Patrick O’Brien
Market: Pink Market
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist